Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.00
Bid: 6.75
Ask: 7.25
Change: 0.00 (0.00%)
Spread: 0.50 (7.407%)
Open: 7.00
High: 7.00
Low: 7.00
Prev. Close: 7.00
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

4 Apr 2008 18:07

Phytopharm PLC04 April 2008 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying Phytopharm plcissuer of existing shares to which voting rights are attached: 2. Reason for the notification (please tick the appropriate box orboxes) An acquisition or disposal of voting rights YES An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify): Placing 3. Full name of person(s) subject to the Mr Klaus Hebbennotification obligation: 4. Full name of shareholder(s) (if different N/Afrom 3.): 5. Date of the transaction (and date on which 28/03/08the threshold is crossed or reached if different) 6. Date on which issuer notified: 02/04/08 7. Threshold(s) that is/are crossed or reached: 10% 8. Notified details: A: Voting rights attached to shares Class/type Situation previous to the Resulting situation after the triggeringof shares Triggering transaction transaction if possibleusing the Number of Number of Number of Number of voting % of votingISIN CODE Shares Voting shares rights rights Rights Direct Direct Indirect xi Direct Indirect xOrdinary 1Pence 5,307,000 5,307,000 9,852,454 Nil 9,852,454 Nil 10.42%GB000686972 B: Financial Instruments Resulting situation after the triggering transaction Type of Expiration Exercise/ Number of voting rights that may % offinancial date Conversion be acquired if the instrument is votinginstrument Period/ Date exercised/ converted. rights Total (A+B) Number of voting rights % of voting rights 9,852,454 10.42% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional Notification using the total voting rights figure ofinformation: 94,544,038 Holding includes shares held by Estatecord Limited (formerly included within the interest of Chakra Limited). 14. Contact name: Zoe McGowan, Company Secretary 15. Contact telephone number: 01480 437697 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Jan 202010:32 amRNSDirector/PDMR Shareholding
13th Jan 20201:29 pmRNSIssue of Equity
23rd Dec 20197:00 amRNSIXICO announces updates to client contracts
20th Dec 20197:00 amRNSStatement re Annual Report and Notice of AGM
9th Dec 20199:26 amRNSPDMR share sale
9th Dec 20197:02 amRNSHolding(s) in Company
9th Dec 20197:00 amRNSPDMR share purchase
5th Dec 20198:22 amRNSDirector/PDMR Shareholding
4th Dec 20197:00 amRNSFinancial Results for the year ended 30 Sept 2019
2nd Dec 20197:00 amRNSIXICO to Present at Alzheimer's Disease Congress
22nd Nov 20197:00 amRNSNotice of Results
5th Nov 20199:00 amRNSIXICO to Present at HD and Ataxia Conferences
4th Nov 20192:51 pmRNSHolding(s) in Company
30th Oct 20199:00 amRNSIXICO to Present at 10th Annual CNS Summit 2019
28th Oct 20197:00 amRNSIXICO announces client contracts and appointed CBO
18th Oct 20197:00 amRNSHolding(s) in Company
15th Oct 20197:00 amRNSTrading Update for year ended 30 September 2019
11th Sep 20197:00 amRNSDirector/PDMR Shareholding
9th Sep 201911:48 amRNSHolding(s) in Company
9th Sep 201911:46 amRNSHolding(s) in Company
5th Sep 20193:43 pmRNSHolding(s) in Company
4th Sep 20195:07 pmRNSHolding(s) in Company
28th Aug 201912:21 pmRNSIssue of Equity
22nd Aug 20197:00 amRNSDirectorate Change
20th Aug 20195:38 pmRNSDirector/PDMR Shareholding
19th Aug 20194:40 pmRNSSecond Price Monitoring Extn
19th Aug 20194:35 pmRNSPrice Monitoring Extension
19th Aug 20197:00 amRNSTrading Update
9th Aug 20197:00 amRNSIXICO provides update on new & current contracts
23rd Jul 201911:05 amRNSSecond Price Monitoring Extn
23rd Jul 201911:00 amRNSPrice Monitoring Extension
11th Jul 20197:00 amRNSDirector and PDMR share purchase
10th Jun 20197:00 amRNSHolding(s) in Company
31st May 20197:00 amRNSHolding(s) in Company
31st May 20197:00 amRNSHolding(s) in Company
31st May 20197:00 amRNSHolding(s) in Company
31st May 20197:00 amRNSHolding(s) in Company
31st May 20197:00 amRNSHolding(s) in Company
22nd May 20197:00 amRNSHalf Yearly Report to 31 March 2019
10th May 20197:00 amRNSNotice of Results
25th Apr 20197:00 amRNSUpdate for first half of year ending 31 March 2019
24th Apr 20197:00 amRNSAnnounces two new biopharmaceutical contracts
12th Apr 20197:00 amRNSChange of Adviser
19th Mar 20194:20 pmRNSHolding(s) in Company
18th Mar 201912:24 pmRNSDirector/PDMR Shareholding
13th Mar 20197:00 amRNSDirector/PDMR Shareholding
5th Mar 20197:00 amRNSLate phase clinical study in Huntington's disease
1st Mar 20197:00 amRNSIXICO chosen for new Medical Imaging & AI Centre
7th Feb 20197:00 amRNSAppointment of Chief Financial Officer
11th Dec 20187:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.